Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$13M Sell
215,895
-183,283
-46% -$8.55M ﹤0.01% 1532
2026
Q1
$14.4M Sell
399,178
-517,173
-56% -$21.6M ﹤0.01% 1331
2025
Q4
$43.2M Buy
916,351
+150,142
+20% +$6.34M 0.01% 717
2025
Q3
$24.9M Buy
766,209
+563,300
+278% +$20.1M 0.01% 1017
2025
Q2
$8.36M Sell
202,909
-294,541
-59% -$11.4M ﹤0.01% 1620
2025
Q1
$20.8M Sell
497,450
-720,490
-59% -$37.5M 0.01% 1115
2024
Q4
$71.4M Buy
1,217,940
+318,630
+35% +$18.8M 0.02% 504
2024
Q3
$62.1M Buy
899,310
+602,506
+203% +$38.9M 0.02% 558
2024
Q2
$18.9M Buy
296,804
+4,294
+1% +$323K 0.01% 1166
2024
Q1
$27.5M Sell
292,510
-8,546
-3% -$688K 0.01% 972
2023
Q4
$22.1M Sell
301,056
-67,702
-18% -$4.34M 0.01% 1085
2023
Q3
$23M Buy
368,758
+4,538
+1% +$305K 0.01% 965
2023
Q2
$26.9M Buy
364,220
+68,009
+23% +$5.18M 0.01% 884
2023
Q1
$23.4M Buy
296,211
+67,160
+29% +$4.85M 0.01% 938
2022
Q4
$15.7M Sell
229,051
-58,140
-20% -$3.69M 0.01% 1200
2022
Q3
$15.2M Sell
287,191
-56,664
-16% -$3.39M 0.01% 1200
2022
Q2
$21.6M Buy
343,855
+42,471
+14% +$2.6M 0.01% 1005
2022
Q1
$20.4M Sell
301,384
-14,211
-5% -$972K 0.01% 1185
2021
Q4
$26.5M Sell
315,595
-5,803
-2% -$465K 0.01% 1060
2021
Q3
$25.1M Sell
321,398
-133,642
-29% -$11.1M 0.01% 1107
2021
Q2
$34.6M Buy
455,040
+178,133
+64% +$12.4M 0.01% 970
2021
Q1
$17.8M Sell
276,907
-11,787
-4% -$708K 0.01% 1417
2020
Q4
$15.6M Buy
288,694
+62,693
+28% +$3.01M 0.01% 1408
2020
Q3
$8.98M Sell
226,001
-163,515
-42% -$6.82M ﹤0.01% 1588
2020
Q2
$15.8M Sell
389,516
-268,814
-41% -$10.6M 0.01% 1186
2020
Q1
$23.6M Buy
658,330
+146,399
+29% +$6.79M 0.01% 815
2019
Q4
$26.1M Sell
511,931
-137,947
-21% -$6.57M 0.01% 1014
2019
Q3
$28.5M Sell
649,878
-444,096
-41% -$19.9M 0.01% 944
2019
Q2
$54.6M Buy
+1,093,974
New +$46.1M 0.02% 632
2014
Q4
Sell
-23,300
Closed -$431K 1618
2014
Q3
$431K Buy
+23,300
New +$498K ﹤0.01% 1391

Other funds holding BRKR

Nuveen's BRKR Position: Q2 2026 in Review

Nuveen reduced its Bruker (BRKR) stake by 46% in Q2 2026, selling an estimated $8.55M and leaving 215,895 shares worth $13M. The position accounts for ﹤0.01% of the portfolio, ranked #1532.

Nuveen first reported a position in BRKR in Q3 2014 and has held it in 30 quarters since. The position peaked at $71.4M in Q4 2024. 415 funds tracked by Wall St. Rank hold BRKR as of Q2 2026.

  • Nuveen held 215,895 shares of Bruker worth $13M as of Q2 2026.
  • Nuveen sold 183,283 Bruker shares in Q2 2026, an estimated $8.55M.
  • Bruker made up ﹤0.01% of Nuveen's portfolio in Q2 2026, its #1532 holding.
  • Nuveen first reported a position in Bruker in Q3 2014 and has held it in 30 quarters since.
  • Nuveen's Bruker position peaked at $71.4M in Q4 2024.
  • 415 funds tracked by Wall St. Rank held Bruker as of Q2 2026.

Based on Nuveen's 13F filing for Q2 2026, filed 11 Aug 2026.